The impact of the introduction of fidaxomicin on the management of Clostridium difficile infection in seven NHS secondary care hospitals in England: a series of local service evaluations

Clostridium difficile infection (CDI) is associated with high mortality. Reducing incidence is a priority for patients, clinicians, the National Health Service (NHS) and Public Health England alike. In June 2012, fidaxomicin (FDX) was launched for the treatment of adults with CDI. The objective of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldenberg, S. D., Brown, S., Edwards, L., Gnanarajah, D., Howard, P., Jenkins, D., Nayar, D., Pasztor, M., Oliver, S., Planche, T., Sandoe, J. A. T., Wade, P., Whitney, L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724367/
https://www.ncbi.nlm.nih.gov/pubmed/26661400
http://dx.doi.org/10.1007/s10096-015-2538-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724367/
https://www.ncbi.nlm.nih.gov/pubmed/26661400
http://dx.doi.org/10.1007/s10096-015-2538-z

Ejemplares similares